Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Novo Biosciences
company
About
Novo Biosciences develops cardiac drugs designed to reverse the life-threatening damage caused by heart attacks.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Medical,Wellness
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Novo Biosciences develops cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. Its drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live a healthier life.The company was founded in 2013 and is headquartered in Bar Harbor, Maine.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.50M
Novo Biosciences has raised a total of
$1.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 7, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 7, 2017 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Novo Biosciences is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
